Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy
Conclusions: The present study suggests that thalassemic patients with chronic hepatitis C genotype 1 infection who did not achieve SVR after a course of therapy with Peg-IFN and RBV may benefit from being retreated with a 72-week regimen.
Source: Hepatitis Monthly - Category: Infectious Diseases Source Type: research
More News: Anemia | Blood Transusion | Cirrhosis | Hepatitis | Hepatitis C | Infectious Diseases | Study | Virology